ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0AB6 Hyloris Pharmaceuticals Sa

0.00
0.00 (0.00%)

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20172017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 1.35M4.37M7.95M5.98M69.18M63.44M61.86M47.61M
Total Current Assets 285k502k3.84M3.74M66.61M53.96M50.8M35.28M
Cash and Equivalents 224k271k2.69M205k64.4M50.01M43.46M30.2M
Total Non-Current Assets -2.19M-4.29M-4.46M-10.19M59.06M48.06M55.05M38.82M
Total Liabilities 3.53M8.65M12.41M16.17M10.12M15.39M6.82M8.79M
Total Current Liabilities 1.06M1.87M3.1M16.15M2.13M14.98M5.77M6.94M
Total Non-Current Liabilities 4.94M13.56M18.62M44k15.98M820k1.79M3.36M
Total Equity -2.19M-4.29M-4.46M-10.19M59.06M48.06M55.05M38.82M
Common Equity 67k79k89k89k129k129k140k140k
Retained Earnings -20.67M-24.32M-28.1M-36.08M-43.23M-54.81M-64.25M-81.01M